Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AKTS
AKTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AKTS News
Aktis Oncology Advances Targeted Radiopharmaceutical Development
2h ago
Newsfilter
Aktis Oncology Reports FY 2025 Financial Results
3h ago
seekingalpha
Wall Street Analysts Adjust Ratings on Key Stocks
Mar 09 2026
Benzinga
FDA Grants Fast Track Designation to AKY-1189 for Urothelial Cancer Treatment
Feb 24 2026
Newsfilter
2026 IPO Market Starts Steadily with $2.6 Billion Raised
Feb 04 2026
renaissancecapital
2026 IPO Market Starts Steadily with $2.6 Billion Raised
Feb 04 2026
renaissancecapital
Wall Street Analysts Adjust Ratings
Feb 03 2026
Benzinga
Helen Kim Acquires 835,000 Shares of AKTS for $15.03M Investment
Jan 13 2026
NASDAQ.COM
Aktis Oncology Closes Upsized IPO Raising $365.4 Million
Jan 13 2026
Globenewswire
Aktis Oncology Prices Upsized IPO at $1 Billion Market Cap, Closes +24%
Jan 11 2026
renaissancecapital
Aktis Oncology Prices Upsized IPO at $318 Million, Targets Solid Tumors
Jan 10 2026
renaissancecapital
Vida Ventures Supports Aktis IPO, Raising $318 Million
Jan 09 2026
Newsfilter
Aktis Oncology Launches $200 Million IPO with $100 Million Investment from Eli Lilly
Jan 09 2026
renaissancecapital
Aktis Oncology Raises $318 Million at $18 per Share in IPO
Jan 09 2026
renaissancecapital
Aktis Oncology Prices Upsized IPO at $18.00 per Share, Raising $318 Million
Jan 09 2026
Globenewswire
Aktis Oncology Prices Upsized IPO at $18.00, Expected to Raise $318 Million
Jan 09 2026
Yahoo Finance
Show More News
